1933 Industries Inc.

TGIFF · Other OTC · USD

0,0049USD

−0,0005 (−9,26 %)Stand 10. Nov., 14:30

Vortag 0,0054

Kennzahlen

Eröffnung
0,0049
Vortag
0,0054
Tagesspanne
0,0049 – 0,0049
52 Wochen
0,0035 – 0,0172
Volumen
2000
Ø Volumen
66.402
Börsenwert
2,55 Mio. $
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
1,6
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

1933 Industries Inc. is a Canadian-based cannabis enterprise actively involved in various segments of the marijuana industry. The company is primarily engaged in cultivating and producing medical marijuana across the United States and Canada, serving both the medicinal and recreational cannabis markets. In addition to its cultivation efforts, 1933 Industries provides a comprehensive array of cannabidiol (CBD)-infused products. This extensive portfolio includes personal care items like lotions and lip balms, ingestibles such as edibles, hemp seed oils, and drink additives, as well as various health and wellness supplements like tinctures and capsules. They also offer vaping solutions, baking ingredients, and tetrahydrocannabinol (THC) concentrates. These CBD lines are marketed under several distinct brands, including Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused. The company further supplies conventional cannabis flowers and concentrates. Its CBD-infused offerings are distributed via a multi-channel strategy, available through retail dispensaries, other retail outlets, and its dedicated e-commerce platform. Based in Vancouver, Canada, the company underwent a name change from Friday Night Inc. to 1933 Industries Inc. in September 2018.

CEO
Brian Farrell
Mitarbeitende
85
Hauptsitz
Vancouver, BC, CA
Sektor
Healthcare
Branche
Drug Manufacturers - Specialty & Generic
Börsengang
22. Mai 2013

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.